Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Inotiv ( (NOTV) ).
On May 14, 2026, Inotiv entered a Ninth Amendment to its credit agreement, adding a $40 million bridge facility and immediately drawing $27.5 million to repay all outstanding revolving loans of about $14.3 million and terminate revolving commitments, while loosening leverage, fixed-charge and liquidity covenants and securing a temporary waiver of cross-defaults tied to missed interest on its convertible notes. The obligations are guaranteed and secured by substantially all company and subsidiary assets, bridge and consent fees were paid in kind, the board expanded to nine directors with a special committee empowered to pursue recapitalization, restructuring or other strategic alternatives, new executive retention and severance protections worth up to roughly $3.9 million were adopted, bylaws were amended to entrench the special committee’s authority, the grace period on a $2.139 million convertible note interest payment was extended to May 29, 2026, and a proposed, insurance-funded settlement was reached on May 13, 2026 to resolve class claims from an August 2025 cybersecurity incident, subject to Indiana state court approval.
These moves collectively underscore Inotiv’s efforts to stabilize its capital structure, retain key leadership and address legal overhangs as it evaluates potential recapitalization, refinancing, reorganization or restructuring paths, with stakeholders facing both the risk of further financial stress, including a possible Chapter 11 scenario, and the prospect that governance changes, relaxed covenants and the cybersecurity settlement could provide a more orderly framework for any forthcoming strategic transaction.
The most recent analyst rating on (NOTV) stock is a Buy with a $1.50 price target. To see the full list of analyst forecasts on Inotiv stock, see the NOTV Stock Forecast page.
Spark’s Take on NOTV Stock
According to Spark, TipRanks’ AI Analyst, NOTV is a Neutral.
The score is primarily held down by weak financial performance (ongoing losses, negative free cash flow, and very high leverage with covenant pressure). Technicals are mixed with only modest near-term stabilization against a longer-term downtrend, while valuation lacks support due to negative earnings and no dividend. Earnings call commentary adds some offset from improving DSA demand/backlog, but near-term liquidity and refinancing risk remain dominant.
To see Spark’s full report on NOTV stock, click here.
More about Inotiv
Inotiv, Inc. operates in the life sciences sector, providing nonclinical and analytical contract research services to pharmaceutical, biotech and related industries. The company focuses on supporting drug discovery and development, and relies on a mix of term loans, convertible notes and credit facilities to finance its operations and strategic initiatives.
Average Trading Volume: 742,856
Technical Sentiment Signal: Sell
Current Market Cap: $10.15M
For a thorough assessment of NOTV stock, go to TipRanks’ Stock Analysis page.